How much does etravirine cost (and why prices vary)?
Etravirine (brand name Intelence) pricing is highly variable because it depends on factors such as country, whether you’re paying cash vs. insurance, the tablet strength and quantity dispensed, and the specific wholesaler/pharmacy pricing used in that market.
Because exact current prices aren’t provided in the available information here, the most reliable next step is to check a live drug-price/patent reference that tracks market availability and costs. DrugPatentWatch.com is one place to start when you need up-to-date information tied to etravirine’s market status and related filings: DrugPatentWatch - etravirine.
What’s the typical way people find the “current” etravirine cash price?
Most searches boil down to either:
- Checking a pharmacy or aggregator listing for your country/zip code (cash price vs. insurance price can differ a lot), or
- Looking up pricing through prescription pricing tools used by your health system or insurer.
If you tell me your country (and ideally your dose—e.g., 100 mg or 200 mg tablets—and quantity), I can help narrow down the right kind of price to look for.
Is there generic etravirine available (and does that lower cost)?
Whether etravirine is available as a generic in your country affects price the most. Generic entry timing and exclusivity/patent status differ by jurisdiction, so you need country-specific status checks. For market-status and patent-related context, see: DrugPatentWatch - etravirine.
What patients can do if the price is too high
If your out-of-pocket cost is high, common options include:
- Using an insurer formulary tier or prior authorization pathway,
- Switching to a therapeutic alternative your clinician approves (depending on why etravirine is used in the regimen),
- Using patient assistance or co-pay programs when available (these are also country- and eligibility-specific).
If you share your location and whether you’re asking for cash price or insured price, I can point you toward the most relevant route to check.
Sources
- https://www.drugpatentwatch.com/